|
| N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Basic information |
Product Name: | N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | Synonyms: | 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-;(R)-Hydroxy Des(boric Acid) BortezoMib;(N-[(1R)-1-hydroxy-3-Methylbutyl]-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninaMide;Bortezomib Impurity 2 (SR-Isomer, Bortezomib Impurity E);SR-Isomer, Bortezomib Impurity E;N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide;BortezoMib IMpurity 2 (SR-IsoMer, EP IMpurity E);Bortezomib Impurity 2 (S,R-Isomer) | CAS: | 289472-78-2 | MF: | C19H24N4O3 | MW: | 356.42 | EINECS: | | Product Categories: | | Mol File: | 289472-78-2.mol | |
| N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Chemical Properties |
Boiling point | 672.0±55.0 °C(Predicted) | density | 1.199±0.06 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | pka | 11.90±0.46(Predicted) | form | Solid | color | White to Off-White |
| N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Usage And Synthesis |
Uses | (R)-Hydroxy Des(boric acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
| N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Preparation Products And Raw materials |
|